EBITDA for Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's current EBITDA (TTM) is -$2.55B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
MRNA
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
-$2.55B
YoY change
-24.8%
5Y CAGR
N/A
Peak year (2021)
$13.53B
Cumulative EBITDA
$12.03B
EBITDA history chart for Moderna (MRNA) from 2016 to 2025
EBITDA history table for Moderna (MRNA) from 2016 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | -$2.55B | -24.8% | ||
| 2024 | -$3.39B | +3.4% | ||
| 2023 | -$3.28B | -133.6% | ||
| 2022 | $9.77B | -27.8% | ||
| 2021 | $13.53B | -2023.3% | ||
| 2020 | -$703.38M | +47.4% | ||
| 2019 | -$477.08M | +15.8% | ||
| 2018 | -$412.05M | +75.1% | ||
| 2017 | -$235.33M | +12.8% | ||
| 2016 | -$208.66M | — |
EBITDA values are taken from Moderna's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Moderna (MRNA) EBITDA is -$2.55B – declined 24.8% year-over-year.
Between 2021 and 2025, Moderna EBITDA plunged 118.9%, falling from $13.53B to -$2.55B.
The dataset's maximum EBITDA sits at $13.53B (2021); the minimum reading of -$3.39B dates to 2024.
Within Healthcare, Moderna (MRNA) ranks 9th among 8 peers we track. The peer median for EBITDA is $24.21B.
Moderna EBITDA by Year
Moderna EBITDA 2025: -$2.55B
Moderna EBITDA in 2025 was -$2.55B, declined 24.8% below 2024.
Moderna EBITDA 2024: -$3.39B
Moderna EBITDA in 2024 was -$3.39B, edged up 3.4% from 2023. This figure represents the lowest annual value in the available history.
Moderna EBITDA 2023: -$3.28B
Moderna EBITDA in 2023 was -$3.28B, plunged 133.6% below 2022.
Moderna EBITDA 2022: $9.77B
Moderna EBITDA in 2022 was $9.77B, declined 27.8% below 2021.
Moderna EBITDA 2021: $13.53B
Moderna EBITDA in 2021 was $13.53B.
See more financial history for Moderna (MRNA).
Sector peers — EBITDA
Companies in the same sector as Moderna, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Moderna's EBITDA?
- Latest reported EBITDA for Moderna (MRNA) is -$2.55B (period ending December 31, 2025).
How has Moderna EBITDA changed year-over-year?
- Moderna (MRNA) EBITDA changed -24.8% year-over-year on the latest annual filing.
When did Moderna EBITDA hit its highest annual value?
- Moderna EBITDA reached its highest annual value of $13.53B in 2021.
What was Moderna EBITDA in 2024?
- Moderna (MRNA) EBITDA in 2024 was -$3.39B.
What was Moderna EBITDA in 2025?
- Moderna (MRNA) EBITDA in 2025 was -$2.55B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MRNA Overview
Company profile, financial tools, and key metrics
MRNA Revenue Counter
Earns $61.61 every second. See per minute, hour, and day.
MRNA Earnings Counter
Loses −$89.49 per second. See per minute, hour, and day.
MRNA Economic Scale
Exceeds Timor-Leste's GDP. Compare with world economies.
MRNA What If Invested
What if you had invested $1,000? See historical returns from any date.
MRNA How It Makes Money
Discover visual breakdown of $1.94B in revenue — where it comes from and where it goes.
MRNA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRNA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRNA Daily Price Character
Explosive · 48.2% historical win rate (green days). Streaks & record days.
MRNA Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.